Medikabazaar, a Mumbai-based B2B (business-to-business) online marketplace for medical supplies, has appointed Jitesh Mathur as senior vice president for business development.
Mathur will be responsible for procurement operations across hospitals and key manufacturer alliances, said an official statement issued by Medikabazaar.
He will also be expected to oversee MedikaRecycle, the startup’s pre-owned medical devices and equipment platform.
Prior to joining Medikabazaar, Mathur was the head of global marketing and sales at SS Innovations, a Singapore-based medical equipment manufacturer.
Mathur held various positions in a 15 year-stint at Philips Healthcare where he served as senior director and head of sales for the South Asia region.
“His [Jitesh Mathur’s] extensive experience will help us bolster our growth plans in terms of strengthening our partner base as well as optimising procurement for a larger number of healthcare providers in order to boost accessibility to high-quality healthcare for end-users,” said Vivek Tiwari, co-founder and chief executive officer, Medikabazaar.
Medikabazaar, operated by Boston Ivy Healthcare Solutions, was founded in April 2015 by Tiwari and Ketan Malkan. The startup aims to optimise procurement costs of medical facilities and equipment for healthcare providers.
Its online platform is said to retail over 250,000 products and facilitates last-mile delivery. The platform also harnesses artificial intelligence to provide medical establishments to estimate stock projections and optimise costs.
The startup caters to over 29,000 hospitals across 23 cities in India. Medikabazaar also plans to expand its operations to the Middle East, Bangladesh and Africa, the statement said.
In July, Medikabazaar appointed former Cox & Kings executive Manoj Mani as the head of technology. The appointment was in line with the startup’s expansion strategy and its plans to ramp up technology capabilities.
It was reported in May that Medikabazaar was in talks to raise over $28 million in a funding round from Delhi-based venture capital firm HealthQuad, Japanese venture capital firm Rebright Partners and Belgian impact investor Kois.
In October 2018, the startup raised around $5 million in its Series A round of funding, led by venture capital firm Healthquad Advisors.